Literature DB >> 1169947

Novel metabolic products of cyclophosphamide in human urine.

P J Cox, L Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1169947     DOI： 10.1016/0006-2952(75)90068-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

Authors:  Fei Li; Andrew D Patterson; Constance C Höfer; Kristopher W Krausz; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

2.  Ames' mutagenic activity in recycled water from an Israeli water reclamation project.

Authors:  I Neeman; R Kroll; A Mahler; R J Rubin
Journal:  Bull Environ Contam Toxicol       Date:  1980-01       Impact factor: 2.151

3.  Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings].

Authors:  P W Mullen
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

4.  Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine.

Authors:  E Yamasaki; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

5.  Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function.

Authors:  G Saul; M Matthias; H Rose; I Pradel
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

6.  Comparison of XAD-2 column and blue cotton batch techniques for isolation of metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline.

Authors:  T Inamasu; H J Luks; J H Weisburger
Journal:  Jpn J Cancer Res       Date:  1988-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.